Untitled
Protein Lipidation
Proteins are precisely directed towards specific cellular membranes or the extracellular space through the covalent attachment of hydrophobic lipid groups. These modifications enable membrane association, regulate protein-protein interactions, and influence signal transduction pathways. There are three main classes of lipid modifications that direct proteins to membranes inside cells:
Myristoylation: Attachment of a 14-carbon saturated fatty acid (myristate).
Palmitoylation: Attachment of a 16-carbon saturated fatty acid (palmitate).
Prenylation: Attachment of isoprenoid groups, specifically farnesyl (C15) or geranylgeranyl (C20) moieties.
Modifications that Attach Hydrophobic Groups
Intracellular Modifications
These modifications typically occur on proteins destined for the cytosolic face of membranes or for soluble functions that require lipid-mediated interactions.
N-terminal Glycine for myristoylation: Myristate is appended to the alpha-amino group of an N-terminal glycine residue via a stable amide bond.
C-terminal sequences for prenylation/isoprenylation: Isoprenoid lipids are attached to cysteine residues near the C-terminus. The specific recognition sequences are:
C-X-X-M (CaaX box) for farnesylation, where M is methionine or serine.
C-X-X-L (CaaX box) for geranylgeranylation, where L is leucine.
In some cases, C-X-C or CC motifs are also substrates for geranylgeranylation.
Cysteine-targeted palmitoylation: Unlike myristoylation and prenylation, palmitoylation occurs on internal cysteine residues via a reversible thioester bond. This allows for dynamic regulation of membrane association and often acts as a switch.
Extracellular Modifications
Proteins associated with the outer leaflet of the plasma membrane, or secreted proteins that remain surface-anchored, often undergo GPI-anchoring.
Glycosyl-phosphatidyl-inositol (GPI-anchor):
Attachment occurs in the endoplasmic reticulum (ER) lumen as a post-translational modification during protein processing.
Specific requirement: A C-terminal hydrophobic signal peptide (often referred to as a '2nd signal peptide') on the nascent protein is recognized and cleaved, and a pre-formed GPI anchor is added en bloc to the new C-terminus.
The GPI anchor tethers the protein to the outer leaflet of the plasma membrane.
Myristoylation
Myristoylation is the covalent attachment of myristate, a saturated 14-carbon fatty acid (C14:0), to the N-terminal glycine residue of a protein.
Features of myristoylation:
Irreversible: The amide bond formed between the myristate and the N-terminal glycine is chemically stable and cannot be easily hydrolyzed or removed once performed.
Co-translational modification: Myristoylation typically occurs as the protein is being synthesized on the ribosome, implying that the N-terminal glycine is exposed early for modification.
Mediated by the enzyme N-myristoyltransferase (NMT): NMT specifically recognizes an N-terminal consensus sequence containing glycine and uses myristoyl-Coenzyme A as a substrate.
Myristic acid (C14:0) derived from myristoyl-Coenzyme A (thioester): This activated form of myristic acid is the donor for the reaction.
Structural formula of the N-terminal linkage: The acyl chain of myristate is linked to the primary amine of the N-terminal glycine:
Calcium-Myristoyl Switch Proteins
These proteins exhibit a conformational change in response to calcium binding, which regulates the exposure and membrane interaction of the myristoyl group.
Myristoylation occurs at N-terminal Gly, but its membrane association is regulated by calcium-induced conformational changes.
Example: Recoverin, an EF-hand calcium regulatory protein primarily found in the photoreceptor cells of the eye. It contains four EF-hand motifs, two of which are high-affinity calcium binding sites.
States of the myristoyl group:
Sequestered: In the absence of calcium (apo-state), the myristoyl group is buried within a hydrophobic pocket of the protein, preventing membrane interaction.
Exposed: Upon binding calcium (holo-state), a conformational change occurs, leading to the extrusion of the myristoyl group, allowing it to insert into the membrane.
Role of Recoverin in Visual Signal Transduction
Recoverin plays a crucial role in adapting the photoreceptor's response to changing light conditions by modulating rhodopsin phosphorylation.
Recoverin's Function:
Primarily found in the retina, where it acts as a calcium sensor.
Regulates the activity of rhodopsin kinase (GRK1), an enzyme responsible for phosphorylating activated rhodopsin, thereby desensitizing the phototransduction cascade.
Mechanism in Dark Conditions:
In the dark, photoreceptors maintain high intracellular calcium levels (approx. ).
High intracellular calcium allows recoverin to bind to calcium via its EF-hand motifs.
Calcium-bound recoverin undergoes a conformational change, exposing its myristoyl group, which then anchors recoverin to the membrane. Membrane-associated recoverin binds to and inhibits rhodopsin kinase.
This inhibition delays rhodopsin phosphorylation and deactivation, effectively prolonging the activation state of rhodopsin and enhancing the photoreceptor's sensitivity to subsequent light stimuli.
Mechanism in Light Conditions:
Upon light exposure, a cascade leads to the closing of cGMP-gated channels, causing intracellular calcium levels to drop significantly (to approx. ).
Recoverin releases calcium and undergoes a conformational change, retracting its myristoyl group back into its hydrophobic pocket.
This dissociation of recoverin from rhodopsin kinase relieves the inhibition, promoting rapid rhodopsin phosphorylation and the recovery of the photoreceptor to its dark-adapted state, thus desensitizing the cell to continuous light.
Functionally, recoverin serves as a sophisticated calcium sensor that finely tunes visual sensitivity, allowing the eye to adapt between widely varying light and dark conditions.
Structural Form of Recoverin
Apo (no ) and Holo (yes ) forms: These refer to the calcium-free and calcium-bound conformations of the protein, respectively.
In recoverin, only two of the four EF-hands are functionally significant for binding and conformational switching in different light conditions.
The extrusion of the myristoyl group upon binding leads to membrane association, which is critical for its inhibitory action on rhodopsin kinase. The hydrophobic myristoyl group acts as a reversible membrane anchor.
Characteristics and Types of Fatty Acids
Protein lipidation involves different types of fatty acids, each with specific chain lengths and saturation states that dictate their interaction with membranes and their biological roles.
Myristic Acid (C14:0): A saturated 14-carbon fatty acid.
Palmitic Acid (C16:0): A saturated 16-carbon fatty acid.
Geranylgeranyl (C20): A 20-carbon isoprenoid, derived from geranylgeranyl pyrophosphate (GGPP), which is synthesized via the mevalonate pathway.
Farnesyl (C15): A 15-carbon isoprenoid, derived from farnesyl pyrophosphate (FPP), also from the mevalonate pathway.
Comparisons of bond types: The covalent linkages vary depending on the lipid modification, influencing their stability and reversibility:
Peptide bond: Connects amino acids in a protein chain. (Not directly involved in lipid attachment).
Amide bond: Unique to myristoylation, linking myristate to the N-terminal glycine. This bond is strong and irreversible.
Thioester bond: Formed in palmitoylation, linking palmitate to a cysteine thiol group. This bond is relatively labile and reversible.
Thioether bond: Formed in prenylation, linking farnesyl or geranylgeranyl groups to a cysteine thiol group. This bond is very stable and irreversible.
Palmitoylation
Palmitoylation is the reversible covalent attachment of palmitic acid (C16:0) to cysteine residues of proteins via a thioester bond. This dynamic modification provides a regulatory switch for protein localization and function.
Characteristics:
Reversible Reaction: This is a key distinguishing feature from myristoylation and prenylation. Palmitoylation is dynamically regulated by two families of enzymes:
Palmitoyl-acyltransferases (PATs): These enzymes (often containing a DHHC zinc finger domain) catalyze the addition of palmitate from palmitoyl-CoA to cysteine residues. There are numerous PATs, each with distinct specificities and subcellular localizations.
Palmitoyl-protein thioesterases (PPTs): These enzymes remove palmitate, hydrolyzing the thioester bond and allowing the protein to de-palmitoylate. This reversibility is crucial for signaling.
Effect on membrane association: Palmitoylation enhances the affinity of proteins for membranes, often targeting them to specific membrane microdomains like lipid rafts. The dynamic on/off switching provides regulatory flexibility, allowing proteins to cycle between membranes, the cytosol, or different membrane compartments in response to cellular signals.
Palmitoylation is a post-translational modification, meaning it occurs after protein synthesis is complete, in contrast to myristoylation and some forms of prenylation, which can be co-translational. Its reversibility underlies its critical role in regulating many signaling proteins (e.g., G-protein alpha subunits, Src family kinases, ion channels).
Prenylation (also Farnesylation and Geranyl-Geranylation)
Prenylation refers to the attachment of isoprenoid lipids (farnesyl or geranylgeranyl) to cysteine residues, typically at the C-terminus of proteins. This modification is crucial for membrane targeting and function of a variety of proteins, particularly small GTPases.
Defined as: Primarily an irreversible co-translational or immediate post-translational modification, involving the formation of a stable thioether bond.
Key to isoprenylation/methylation: Isoprenoid building blocks are derived from the mevalonate pathway:
Farnesyl pyrophosphate (FPP): A C15 isoprenoid donor.
Geranylgeranyl pyrophosphate (GGPP): A C20 isoprenoid donor.
These hydrophobic lipids are crucial for anchoring proteins to membranes.
Sequence Patterns (CaaX box):
The canonical CaaX box consists of a Cysteine (C), two aliphatic amino acids (a), and a C-terminal amino acid (X).
Definition: C = Cysteine; a = aliphatic amino acid (e.g., alanine, valine, leucine, isoleucine); X = the C-terminal amino acid, which determines the specificity for farnesylation or geranylgeranylation (e.g., S, M for farnesylation; L, F for geranylgeranylation).
Other motifs like C-X-C or CC can also be substrates, particularly for geranylgeranylation of some Rab GTPases.
Several enzymes are involved in a series of tightly coupled reactions that modify the CaaX box:
Prenyltransferase activity: Adds farnesyl or geranylgeranyl groups to the cysteine. This is always the first step for CaaX proteins.
Proteolytic cleavage: Subsequently cleaves the last three amino acids (-aaX) from the C-terminus.
Methylation: Lastly, methylates the newly exposed C-terminal carboxyl group of the prenylated cysteine, which neutralizes the negative charge and enhances hydrophobicity, reinforcing membrane binding.
Enzymatic Steps in Prenylation
These enzymes work sequentially to complete the prenylation modification of CaaX proteins:
Farnesyl Transferase (FTase): Catalyzes the addition of a farnesyl group from farnesyl-pyrophosphate (FPP) to the cysteine of CaaX proteins where X is typically Ser, Met, Ala, or Gln (e.g., Ras proteins).
Geranylgeranyl Transferase I (GGTase-I): Catalyzes the addition of a geranylgeranyl group from geranylgeranyl-pyrophosphate (GGPP) to the cysteine of CaaX proteins where X is typically Leu or Phe (e.g., Rho family GTPases).
CaaX Protease (Rce1/Ste24p): After prenylation, this endoprotease removes the -aaX tripeptide from the C-terminus, creating a new C-terminal prenylated cysteine.
CaaX Methyltransferase (Icmt/Ste14p): This enzyme, in the ER, methylates the alpha-carboxyl group of the prenylated cysteine using S-Adenosylmethionine (Ado-Met) as the methyl donor. This final step is crucial for full membrane anchoring and biological activity of many prenylated proteins.
Glycosyl-Phosphatidyl-Inositol (GPI-Anchor)
A GPI anchor is a complex glycolipid that tethers proteins to the outer leaflet of the plasma membrane. This modification is critical for a diverse array of cell surface proteins involved in cell adhesion, signal transduction, and host-pathogen interactions.
Modification occurs in the ER: The synthesis and attachment of the GPI anchor are highly coordinated events that take place in the lumen of the endoplasmic reticulum.
GPI-anchor attaches at the C-terminal end of the protein: Specifically, a pre-formed GPI precursor is attached to the new C-terminus of the protein after proteolytic cleavage of a C-terminal signal peptide.
Specific sequences are recognized for the GPI attachment: Proteins destined for GPI-anchoring possess two distinct signal peptides: an N-terminal signal peptide (for translocation into the ER lumen) and a C-terminal hydrophobic signal peptide (which contains cleavage information). The C-terminal '2nd signal peptide' is recognized by the GPI transamidase complex, which cleaves it and attaches the GPI anchor to a specific amino acid (omega site) near the original C-terminus.
Mechanism of GPI-Attachment
The C-terminal GPI anchor signal is encoded in the genome and guides the protein to the GPI attachment machinery.
Cleavage can lead to protein shedding: Many GPI-anchored proteins can be released from the cell surface by cleavage of the GPI anchor itself. This shedding can be mediated by specific phospholipases or proteases.
Example: PI-PLC (phosphoinositide phospholipase C) is an extracellular enzyme that can cleave the phosphodiester bond within the GPI anchor, releasing the protein from the membrane into the extracellular space. This process is important in various physiological and pathological contexts.
Characteristics of GPI Attachment
GPI-anchor attachment is generally irreversible under normal physiological conditions due to the stable phosphodiester and amide linkages. However, as noted, specific phospholipases or other enzymes can cleave the anchor chain and release the protein from the membrane, allowing for a regulated release mechanism. These proteins are often found in lipid rafts.
Prion Protein and Associated Diseases
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of rare, fatal neurodegenerative disorders characterized by the misfolding and aggregation of the cellular prion protein (PrPC) into an infectious, pathogenic form (PrPSc).
PrP (Prion protein) and its role in diseases like:
Creutzfeldt-Jakob Disease (CJD): Can be sporadic (most common), familial (due to PRNP gene mutations), or iatrogenic (due to medical procedures or contaminated tissues). It causes rapidly progressive dementia.
Bovine Spongiform Encephalopathy (BSE) or 'Mad Cow Disease': Affects cattle and is caused by exposure to infected cattle feed. It is transmissible to humans as variant CJD (vCJD) through consumption of infected beef products.
Kuru: A historical disease associated with endocannibalism (ingestion of infected human brain tissue) among the Fore people of Papua New Guinea. Noted for its extremely long incubation period (decades) and cerebellar ataxia.
Fatal Familial Insomnia (FFI): A rare, inherited (autosomal dominant) neurodegenerative disease linked to a specific mutation (D178N) in the PRNP gene, leading to severe insomnia, dysautonomia, and eventually dementia.
All these diseases are linked to severe neurodegeneration, widespread neuronal loss, vacuolation (spongiform encephalopathy), cognitive decline, motor dysfunction, and are ultimately fatal.
Prion proteins PrPC (cellular isoform) are key to neuroprotection and signaling due to their location on the cell surface, supported by GPI anchors. PrPC is a glycoprotein rich in alpha-helical structures.
Misfolding from PrPC to PrPSc is crucial in prion pathogenesis. PrPSc (scrapie isoform) is characterized by a high beta-sheet content, protease resistance, and a propensity to aggregate into amyloid fibrils. PrPSc can act as a template, inducing normal PrPC to misfold into the pathogenic form, thus propagating the disease.
Importance of Copper Ions
Why are copper ions significant? PrPC contains a flexible N-terminal domain with octapeptide repeats that bind copper ions (). Their special characteristic is their ability to cycle between redox states (), affecting prion function. Copper binding is thought to be involved in PrPC's physiological roles, such as antioxidation, neuroprotection, and synaptic function.
Dysregulation of copper binding or cellular copper homeostasis has been implicated in prion disease pathogenesis, potentially influencing PrPC trafficking, stability, and its conversion to PrPSc.
Other Post-Translational Modifications (PTMs)
Beyond lipidation, cysteine residues are highly versatile and participate in various crucial redox-sensitive PTMs that regulate protein function, often in response to oxidative stress.
Cysteine thiols can undergo modifications during oxidative stress, including:
Sulfenylation (S-hydroxylation): The transient oxidation of a cysteine thiol () to a sulfenic acid (). This is an important intermediate in redox signaling and protects the thiol from further irreversible oxidation.
S-nitrosylation: The covalent attachment of a nitric oxide (NO) group to a cysteine thiol, forming an S-nitrosothiol (). This is a key mechanism for NO signaling, regulating protein activity, trafficking, and stability.
Other modifications include S-glutathionylation, disulfide bond formation, and irreversible oxidation to sulfinic () and sulfonic acids ().
These redox-based modifications are critical for controlling protein function. Imbalances in these modifications or persistent oxidative stress can lead to protein misfolding and aggregation, which are major hallmarks of many neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, and prion diseases).
Cysteine thiol groups are important not only for their high nucleophilicity but especially due to their redox sensitivity, making them prime targets for reversible modification, thereby acting as crucial switches in cellular signaling pathways and responses to oxidative